AMHERST, N.Y., June 27, 2007 (PRIME NEWSWIRE) -- HealthSport, Inc. (OTCBB:HSPO), a fully integrated developer, manufacturer and marketer of branded nutritional supplements in a one-of-a-kind edible film strip delivery system, announced today its wholly owned-subsidiary, Enlyten, Inc., has reached an agreement with Duke University to develop a clinical study and research program of the Company's Enlyten(tm) SportStrips(tm), an edible thin film strip that delivers electrolytes to the body through buccal absorption.
Enlyten SportStrips replace the electrolytes lost during vigorous workouts through a patented delivery system. This mode of absorption is very different from all electrolyte delivery predecessors. When placed between the cheek and gum, gastric absorption is bypassed speeding higher levels of electrolytes directly into the bloodstream. Not only does it dramatically improve hydration on a cellular level, but it also helps athletes to avoid the problems caused by excessive fluid consumption which is often associated with sports drinks. Known scientifically to be an extremely fast and efficient way to deliver drugs into the bloodstream, buccal absorption bypasses the inherent drawbacks of gastric absorption, an Achilles heel for many athletes who struggle with fatigue, cramping and hydration issues.
The study, which will be done in a number of phases conducted over the next two years, will determine the effectiveness of the electrolyte strips, as well as overall opinion of athletes using the product. The studies will be completed in the Coach Michael W. Krzyzewski Human Performance Laboratory within Duke Sports Medicine and will use surveys and test human subjects to determine the utility, palatability, and functionality of the product. The studies will also test electrolytes and their relationship to athletic performance, as well as their rate of absorption. Researchers will conduct tests involving various delivery methods as controls, including sports drinks and electrolyte strips.
"We are honored to be working with Duke University and its esteemed staff in conducting clinical surveys and research on our Enlyten SportStrips," said Dan Kelly, President of HealthSport, Inc. "We have the utmost respect for the university and its research capabilities. The research results that have been released from the University thus far have been extraordinary, and they have made many breakthroughs. This partnership will enable us to better understand athletes on all levels and how the electrolytes interact with their bodies as they use the Enlyten SportStrips. With the variety of electrolyte replenishment products on the market now, we feel it is important to provide as much scientific evidence as possible that shows our product will keep athletes replenished during vigorous workouts, help them get the most out of the training, and maximize their performance levels."
"Duke Sports Medicine is pleased to have the opportunity to further study a product which has the potential to change the way we view electrolyte replenishment. This product has already proven to be a fast, efficient, and convenient method for delivering electrolytes to athletes. These basic science studies will enable us to better understand the role of electrolyte imbalance in endurance which could be also be related to workplace fatigue. Significantly, a major cause of death in Third world countries is electrolyte balance associated with disease. Future research plans using HealthSport's thin multilayer strip technology may well focus on applications in these areas using data gained from the studies of athletes," stated Duke's Senior Research Associate, Anthony Seaber. Serving as the Director of the Orthopedic Research Laboratories, Mr. Seaber has extensive experience in the field of scientific research, having published over 250 scientific articles in major medical journals.
If you would like to receive e-mail announcements about HSPO, please sign up at the following website: http://www.Directstocknews.com/HSPO.
About HealthSport, Inc.
HealthSport (http://www.healthsportinc.com) is a fully integrated developer, manufacturer and marketer of unique and proprietary branded and private label edible film strip nutritional supplements and over-the-counter drugs. The Company owns two subsidiaries -- Enlyten, Inc. and InnoZen, Inc. Enlyten was created to market and distribute HealthSport's products. InnoZen (http://www.innozen.com) is the preeminent formulator, developer and manufacturer of edible film strips that deliver drug actives through buccal (between the cheek and gum) absorption. InnoZen's proprietary edible film strip delivery technology is superior to any other competitive edible film strips currently on the market. InnoZen has five patents pending and has developed numerous trade secrets which it incorporates in the development and manufacturing process of edible film strips. The company's Enlyten(tm) SportStrips(tm) (http://enlytenstrips.com), an edible film electrolyte strip, has recently undergone and completed pre-market testing conducted in conjunction with physicians and scientists at Duke University Sports Medicine & The Michael W. Krzyzewski Human Performance Laboratory ("K Lab") (http://klab.surgery.duke.edu). Preliminary findings of these tests suggest that the Enlyten electrolyte strip delivers meaningful amounts of electrolytes to the body in a safe, fast and effective manner.
Special Note Regarding Forward-Looking Statements: Statements in this news release about anticipated or expected future revenue or growth or expressions of future goals or objectives, including statements regarding whether current plans to grow and strengthen the Company's existing business, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements in this release are based upon information available to the Company on the date of this release. Any forward-looking statements involve risks and uncertainties, including the risk that the Company will be unable to grow or strengthen its business due to a lack of capital or an inability to identify acquisition candidates and that the Company may not realize anticipated cost savings or revenue growth opportunities associated with any acquisitions, planned or otherwise. Additionally, forward-looking statements concerning the performance of the Company's business are based on current market conditions and risks, which may change as the result of certain regulatory, competitive or economic events, as well as those risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, which could cause actual events or results to differ materially from the events or results described in the forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on these forward-looking statements.